In the News

Recent Coverage of HMS in the News
June 17, 2012

More than 15,000 people arriving in Boston for the Biotechnology Industry Organization convention opening Monday will see a Massachusetts life sciences sector that has grown and changed noticeably since the city last played host to BIO in 2007. HMS is mentioned for receiving NIH grants totaling $200.4 million.

June 17, 2012

The New England Journal of Medicine is celebrating its 200th anniversary this year. The Boston Globe features a look at how the Journal editors have shaped our understanding of disease and treatment, balancing the new with the necessary, and of what it means to be a doctor. Several past discoveries by HMS faculty are highlighted.

June 15, 2012

People are increasingly turning to the Internet for information on all kinds of healthissues. Jerome Groopman, the Dina and Raphael Recanati Professor of Medicine; Pamela Hartzband, HMS assistant professor of medicine; and Aditi Nerurkar, HMS research fellow in medicine at Beth Israel Deaconess Medical Center, are quoted.

June 15, 2012

Pfizer, the world’s largest drug company, is embedding operations in Boston, San Francisco, New York and San Diego, often in the very same buildings where famed academic institutions have labs.

June 14, 2012

Angelo Volandes, HMS assistant professor of medicine at Massachusetts General Hospital, authored this article about improving communication with patients and physicians.

June 14, 2012

For the first time since construction was halted in late 2009, Harvard University said Wednesday that it expects to resume work in 2014 on its planned science complex in Allston, the single largest invest ment in a science facility the 375-year-old Ivy League institution has ever made.

June 14, 2012

A small but growing cadre of scientists are using themselves as research subjects. Work by George Church, the Robert Winthrop Professor of Genetics at HMS is mentioned, and John Halamka, HMS professor of medicine at Beth Israel Deaconess Medical Center, is quoted.

June 14, 2012

Screening the genomes of healthy people may give important clues about their cancer risk, according to a study that suggests advanced DNA technology might be employed early in a patient’s health assessment. Robert Green, HMS lecturer on medicine at Brigham and Women’s Hospital, is quoted.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.